Skip to content
Screener

Twist Bioscience Corporation TWST Total Liabilities & Equity

Total Liabilities & Equity at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$113.17B+11.8%
Danaher logo
DanaherDHR
$92.37B+13.2%
Azenta logo
AzentaAZTA
$1.88B
Agilent Technologies logo
Agilent TechnologiesA
$13.07B+7.5%
Illumina logo
IlluminaILMN
$6.65B+9.2%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$1.31B-6.7%

Other financials

Income statement

See full
Revenue$110.7M+19.3%
Gross profit$57.1M+24.1%
Operating income-$45.9M-10.4%
Net income-$44.0M-11.9%
EPS (diluted)-$0.71-7.6%

Balance sheet

See full
Cash & equivalents$124.9M-41.4%
Total debt$110.8M+16.3%
Total equity$455.1M+3.4%
Total assets$676.2M+13.5%

Cash flow

See full
Operating cash flow-$17.6M-35.2%
CapEx$7.9M+90.3%
Free cash flow-$25.4M-48.5%

Valuation

See full
Market cap$6.84B+338%
Enterprise value$6.83B+370%
P/S16.7×+12.4×

Profitability

See full
Gross margin52.1%+5.4pp
Operating margin-33.9%-9.9pp
Net margin-19.8%-7.7pp
FCF margin-23.2%+7.0pp

Returns & leverage

See full
Return on equity-18.2%-6.3pp
Debt / equity0.2×0.0×
Current ratio2.7×-1.8×

Where this comes from

Reported directly by Twist Bioscience Corporation in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.

The source filing: Twist Bioscience Corporation’s 10-Q, filed May 4, 2026.

Filed
May 4, 2026, 4:28 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q1 2026
Accession
0001581280-26-000040
(In thousands, except per share data)March 31,2026September 30,2025
Commitments and contingencies (Note 11)
Stockholders’ equity
Common stock, $0.00001 par value —200,000 and 200,000 shares authorized at March 31, 2026 and September 30, 2025, respectively; 62,154 and 60,632 shares issued and outstanding at March 31, 2026 and September 30, 2025, respectively$1
Additional paid-in capital1,849,8381,793,163
Accumulated other comprehensive loss(639)(627)
Accumulated deficit(1,394,106)(1,319,578)
Total stockholders’ equity$455,094$472,958
Total liabilities and stockholders’ equity$676,214$641,861

Item 1. Financial Statements (unaudited)

FAQ

What is Twist Bioscience Corporation's total liabilities & equity?
Twist Bioscience Corporation (TWST) reported total liabilities & equity of $676.21M in Q1 2026.
How has Twist Bioscience Corporation's total liabilities & equity changed year-over-year?
Twist Bioscience Corporation's total liabilities & equity increased by 13.5% year-over-year, from $595.62M to $676.21M.
What is the long-term trend for Twist Bioscience Corporation's total liabilities & equity?
Over 4 years (2021 to 2025), Twist Bioscience Corporation's total liabilities & equity has grown at a -2.2% compound annual growth rate (CAGR), from $702.1M to $641.86M.
What does total liabilities & equity mean?
Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.

Ask your AI about Twist Bioscience Corporation's total liabilities & equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude